Abstract
23P Prediction of response to atezolizumab plus nab-paclitaxel in unresectable locally advanced triple-negative breast cancer (TNBC): The clinical usefulness of PD-L1 mRNA expression in plasma-derived exosomes
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have